CADL
Candel Therapeutics, Inc.Company with tickers: CADL
CIK
1841387
CUSIP
137404109
Shares Outstanding
73,246,927
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-31 | Manning Paul B | 10% Owner | Award | 4,618 |
| 2026-03-31 | PAPA JOSEPH C | Director, President and CEO | Award | 2,795 |
| 2026-03-31 | Loggia Nicoletta | Director | Award | 779 |
| 2026-02-23 | Manning Paul B | 10% Owner | Buy | 550,458 |
| 2026-02-23 | Manning Paul B | 10% Owner | Other | 1,303,752 |
| 2026-01-26 | Tyagarajan Seshu | Chief Technology Officer | Award | 154,000 |
| 2026-01-26 | Nichols William Garrett | Chief Medical Officer | Award | 136,500 |
| 2026-01-26 | Schoch Charles | Chief Financial Officer | Award | 232,000 |
| 2026-01-26 | Tak Paul Peter | Director, Chief Executive Officer | Award | 629,000 |
| 2026-01-26 | Barone Francesca | Chief Scientific Officer | Award | 232,000 |
| 2025-07-28 | Nichols William Garrett | Chief Medical Officer | Convert | 937 |
| 2025-07-28 | Nichols William Garrett | Chief Medical Officer | Sell | 937 |
| 2025-07-28 | Nichols William Garrett | Chief Medical Officer | Convert | 937 |
| 2025-06-30 | Nichols William Garrett | Chief Medical Officer | Convert | 781 |
| 2025-06-30 | Nichols William Garrett | Chief Medical Officer | Sell | 781 |
| 2025-06-30 | Nichols William Garrett | Chief Medical Officer | Convert | 781 |
| 2025-06-25 | Manning Paul B | 10% Owner | Other | 1,303,752 |
| 2025-06-25 | Manning Paul B | 10% Owner | Award | 1,070,663 |
| 2025-06-25 | Martell Christopher | Director | Other | 152,000 |
| 2025-06-25 | Martell Christopher | Director | Award | 111,349 |
| 2025-06-25 | Schoch Charles | Chief Financial Officer | Award | 5,353 |
| 2025-06-25 | Barone Francesca | Chief Scientific Officer | Award | 4,282 |
| 2025-06-25 | Tyagarajan Seshu | Chief Technology Officer | Award | 5,353 |
| 2025-06-25 | Tak Paul Peter | Director, Chief Executive Officer | Award | 42,826 |
| 2025-06-25 | Loggia Nicoletta | Director | Award | 2,141 |
| 2025-06-25 | Nabel Gary J. | Director, Chief Innovation Officer | Award | 5,353 |
| 2025-06-25 | PAPA JOSEPH C | Director, President and CEO | Other | 38,032 |
| 2025-06-25 | PAPA JOSEPH C | Director, President and CEO | Award | 64,239 |
| 2025-06-20 | Schoch Charles | Chief Financial Officer | Award | 50,000 |
| 2025-06-17 | Nabel Gary J. | Director, Chief Innovation Officer | Award | 14,240 |
| 2025-06-17 | Nguyen Diem | Director | Award | 14,240 |
| 2025-06-17 | PAPA JOSEPH C | Director, President and CEO | Award | 14,240 |
| 2025-06-17 | Benz Edward J. JR | Director | Award | 14,240 |
| 2025-06-17 | Gaeta Renee | Chief Financial Officer | Award | 14,240 |
| 2025-06-17 | Loggia Nicoletta | Director | Award | 14,240 |
| 2025-06-17 | Manning Paul B | 10% Owner | Award | 14,240 |
| 2025-06-17 | Martell Christopher | Director | Award | 14,240 |
| 2025-06-04 | Radhakrishnan Maha | Director | Award | 28,480 |
| 2025-06-04 | Radhakrishnan Maha | Director | Other | 0 |
| 2025-03-19 | Tak Paul Peter | Director, Chief Executive Officer | Sell | 400 |
| 2025-03-18 | Nichols William Garrett | Chief Medical Officer | Convert | 4,584 |
| 2025-03-18 | Nichols William Garrett | Chief Medical Officer | Sell | 45,316 |
| 2025-03-18 | Nichols William Garrett | Chief Medical Officer | Convert | 4,584 |
| 2025-03-18 | Barone Francesca | Chief Scientific Officer | Convert | 18,000 |
| 2025-03-18 | Barone Francesca | Chief Scientific Officer | Sell | 32,146 |
| 2025-03-18 | Barone Francesca | Chief Scientific Officer | Convert | 18,000 |
| 2025-03-18 | Tak Paul Peter | Director, Chief Executive Officer | Sell | 25,772 |
| 2025-03-17 | Schoch Charles | Chief Financial Officer | Sell | 5,000 |
| 2025-03-17 | Tyagarajan Seshu | Chief Technology Officer | Convert | 20,000 |
| 2025-03-17 | Tyagarajan Seshu | Chief Technology Officer | Sell | 31,278 |
| 2025-02-21 | Aguilar-Cordova Estuardo | 10% Owner | Other | 10,582 |
| 2025-02-12 | Tyagarajan Seshu | Chief Technology Officer | Award | 65,000 |
| 2025-02-12 | Schoch Charles | Chief Financial Officer | Award | 83,000 |
| 2025-02-12 | Nichols William Garrett | Chief Medical Officer | Award | 107,250 |
| 2025-02-12 | Tak Paul Peter | Director, Chief Executive Officer | Award | 525,000 |
| 2025-02-12 | Barone Francesca | Chief Scientific Officer | Award | 115,000 |
| 2025-02-10 | Aguilar-Cordova Estuardo | 10% Owner | Other | 31,335 |
| 2025-01-15 | Nichols William Garrett | Chief Medical Officer | Sell | 10,428 |
| 2025-01-15 | Barone Francesca | Chief Scientific Officer | Sell | 13,534 |
| 2025-01-15 | Tyagarajan Seshu | Chief Technology Officer | Sell | 14,322 |
| 2025-01-15 | Schoch Charles | Chief Financial Officer | Sell | 9,511 |
| 2025-01-15 | Tak Paul Peter | Director, Chief Executive Officer | Sell | 21,704 |
| 2025-01-08 | Barone Francesca | Chief Scientific Officer | Sell | 13,673 |
| 2025-01-08 | Schoch Charles | Chief Financial Officer | Sell | 9,971 |
| 2025-01-08 | Tak Paul Peter | Director, Chief Executive Officer | Sell | 21,172 |
| 2025-01-08 | Tyagarajan Seshu | Chief Technology Officer | Sell | 14,545 |
| 2025-01-08 | Nichols William Garrett | Chief Medical Officer | Sell | 10,799 |
| 2024-12-27 | Aguilar-Cordova Estuardo | 10% Owner | Other | 50,000 |
| 2024-12-26 | Aguilar-Cordova Estuardo | 10% Owner | Other | 50,000 |
| 2024-12-24 | Aguilar-Cordova Estuardo | 10% Owner | Other | 50,000 |
| 2024-12-23 | Aguilar-Cordova Estuardo | 10% Owner | Other | 50,000 |
| 2024-12-20 | Aguilar-Cordova Estuardo | 10% Owner | Other | 100,000 |
| 2024-12-16 | Manning Paul B | 10% Owner | Other | 1,681,000 |
| 2024-12-16 | Manning Paul B | 10% Owner | Buy | 500,000 |
| 2024-12-12 | Aguilar-Cordova Estuardo | 10% Owner | Other | 200,000 |
| 2024-12-11 | Aguilar-Cordova Estuardo | 10% Owner | Other | 200,000 |
| 2024-12-06 | Aguilar-Cordova Estuardo | 10% Owner | Other | 20,000 |
| 2024-12-05 | Aguilar-Cordova Estuardo | 10% Owner | Other | 20,000 |
| 2024-12-04 | Aguilar-Cordova Estuardo | 10% Owner | Other | 20,000 |
| 2024-11-29 | Tyagarajan Seshu | Chief Technology Officer | Sell | 20,392 |
| 2024-11-29 | Tak Paul Peter | Director, Chief Executive Officer | Sell | 48,847 |
| 2024-11-29 | Nichols William Garrett | Chief Medical Officer | Sell | 13,935 |
| 2024-11-29 | Barone Francesca | Chief Scientific Officer | Sell | 22,081 |
| 2024-11-25 | Aguilar-Cordova Estuardo | 10% Owner | Other | 20,000 |
| 2024-11-21 | Tak Paul Peter | Director, Chief Executive Officer | Convert | 12,900 |
| 2024-11-21 | Tak Paul Peter | Director, Chief Executive Officer | Convert | 12,900 |
| 2024-11-08 | Aguilar-Cordova Estuardo | 10% Owner | Other | 7,500 |
| 2024-11-07 | Aguilar-Cordova Estuardo | 10% Owner | Other | 7,500 |
| 2024-11-06 | Aguilar-Cordova Estuardo | 10% Owner | Other | 7,500 |
| 2024-11-01 | Aguilar-Cordova Estuardo | 10% Owner | Other | 7,500 |
| 2024-10-31 | Aguilar-Cordova Estuardo | 10% Owner | Other | 7,500 |
| 2024-10-30 | Aguilar-Cordova Estuardo | 10% Owner | Other | 6,000 |
| 2024-10-28 | Aguilar-Cordova Estuardo | 10% Owner | Other | 11,711 |
| 2024-10-25 | Aguilar-Cordova Estuardo | 10% Owner | Other | 1,597 |
| 2024-10-24 | Aguilar-Cordova Estuardo | 10% Owner | Other | 16,427 |
| 2024-10-15 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 10,412 |
| 2024-10-14 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 15,000 |
| 2024-10-11 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 15,000 |
| 2024-10-11 | Aguilar-Cordova Estuardo | 10% Owner | Other | 2,074,942 |
| 2024-10-03 | Aguilar-Cordova Estuardo | 10% Owner | Sell | 1,800 |